Insider Trading & Ownership - REINHARDT MAX

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for REINHARDT MAX
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-06-06
Sale
2023-06-07
9:28 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
2,153$38.42$82,71029,225
(Direct)
View
2022-10-07
Sale
2022-10-11
4:13 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
1,380$58$80,04031,378
(Direct)
View
2022-06-06
Sale
2022-06-08
7:40 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
5,250$61.66$323,73752,150
(Direct)
View
2022-04-21
Sale
2022-04-25
4:12 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
9,824$73.25$719,647129,650
(Direct)
View
2022-04-18
Sale
2022-04-20
8:25 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
28,026$73.27$2,053,491401,974
(Direct)
View
2021-07-02
Sale
2021-07-06
6:14 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
421$59.76$25,15917,500
(Direct)
View
2021-06-04
Sale
2021-06-08
4:16 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
3,500$60.69$212,40610,500
(Direct)
View
2021-01-06
Sale
2021-01-08
4:39 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President
110$60.81$6,68914,000
(Direct)
View
2020-11-13
Sale
2020-11-17
5:28 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President
25,000$63.38$1,584,390164,000
(Direct)
View
2020-09-17
Sale
2020-09-21
6:23 pm
Pacira BioSciences Inc.PCRXREINHARDT MAX
President
25,420$59.81$1,520,318189,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-10
Option Award
2024-06-12
4:35 pm
N/A
2031-06-10
Orthofix Medical Inc.OFIXREINHARDT MAX
President, Global Spine
190,731$0205,132
(Direct)
View
2024-06-10
Option Award
2024-06-12
4:35 pm
N/A
N/A
Orthofix Medical Inc.OFIXREINHARDT MAX
President, Global Spine
14,401$13.02205,132
(Direct)
View
2022-06-08
Option Award
2022-06-08
7:40 pm
N/A
2032-06-08
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
27,850$052,150
(Direct)
View
2022-04-21
Exercise
2022-04-25
4:12 pm
N/A
2029-07-02
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
12,500$0129,650
(Direct)
View
2022-04-21
Exercise
2022-04-25
4:12 pm
N/A
N/A
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
12,500$42.54129,650
(Direct)
View
2022-04-18
Exercise
2022-04-20
8:25 pm
N/A
2029-07-02
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
37,500$0401,974
(Direct)
View
2022-04-18
Exercise
2022-04-20
8:25 pm
N/A
N/A
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
37,500$42.54401,974
(Direct)
View
2021-06-09
Option Award
2021-06-11
8:40 pm
N/A
2031-06-09
Pacira BioSciences Inc.PCRXREINHARDT MAX
President, Rest of World
24,500$035,000
(Direct)
View
2020-11-13
Exercise
2020-11-17
5:28 pm
N/A
2029-07-02
Pacira BioSciences Inc.PCRXREINHARDT MAX
President
25,000$0164,000
(Direct)
View
2020-11-13
Exercise
2020-11-17
5:28 pm
N/A
N/A
Pacira BioSciences Inc.PCRXREINHARDT MAX
President
25,000$42.54164,000
(Direct)
View
2020-09-17
Exercise
2020-09-21
6:23 pm
N/A
2029-07-02
Pacira BioSciences Inc.PCRXREINHARDT MAX
President
25,000$0189,000
(Direct)
View
2020-09-17
Exercise
2020-09-21
6:23 pm
N/A
N/A
Pacira BioSciences Inc.PCRXREINHARDT MAX
President
25,000$42.54189,000
(Direct)
View
2020-06-09
Option Award
2020-06-11
6:31 pm
N/A
2030-06-09
Pacira BioSciences Inc.PCRXREINHARDT MAX
President
49,000$049,000
(Direct)
View